...
首页> 外文期刊>Archives of Physical Medicine and Rehabilitation >Ultraviolet-c irradiation in the management of pressure ulcers in people with spinal cord injury: A randomized, placebo-controlled trial
【24h】

Ultraviolet-c irradiation in the management of pressure ulcers in people with spinal cord injury: A randomized, placebo-controlled trial

机译:紫外线照射治疗脊髓损伤患者的压疮:一项随机,安慰剂对照的试验

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To compare the effects of ultraviolet-C (UVC) with placebo-UVC on pressure ulcer healing in individuals with spinal cord injury (SCI). Design: Double-blind randomized trial with stratification for ulcer location to buttock or lower extremity. Subjects were followed up for 1 year postintervention. Setting: Rehabilitation institution. Participants: Adult inpatients and outpatients (N=43) with SCI and stage 2 to 4 pressure ulcers (n=58). Interventions: Ulcers and periwound skin were irradiated 3 times per week using UVC or placebo-UVC. The endpoint was wound closure or hospital discharge without closure. Main Outcome Measures: Primary outcome was weekly percent area relative to baseline. Secondary outcomes were mean percent area change between consecutive weeks, surface appearance, weeks to closure, and impact on quality of life and wound status postintervention. Results: Groups were similar at baseline for all demographic characteristics except ulcer duration (P=.02). Groups were similar when healing was compared overall. Subgroup analysis showed that the percent area relative to baseline for stage 2 buttock ulcers was significantly smaller in the group receiving UVC compared with placebo at weeks 3, 5, and 7. During weeks 1 through 8, these ulcers were 26% to 76% of baseline area using UVC versus 111% to 180% for placebo (achieved significant level [ASL],.03-.08; effect size, 0.5-0.8). Groups were similar in the percent area relative to baseline for stage 2 lower extremity ulcers. Group mean percent area change between consecutive weeks for all stage 2 ulcers was 36.6% with the use of UVC and 5.8% for placebo (ASL=.09). There were no group differences in the percent area relative to baseline and the mean percent area change between consecutive weeks for stage 3 to 4 ulcers. Groups were similar for all other secondary outcomes. Conclusions: UVC is beneficial for stage 2 buttock ulcers. Further studies are warranted using a larger sample size, carefully considered exclusion criteria, and strategies to ensure homogeneity of the groups that are being compared.
机译:目的:比较紫外线-C(UVC)和安慰剂-紫外线对脊髓损伤(SCI)患者压力性溃疡愈合的影响。设计:双盲随机试验,分层分析溃疡位于臀部或下肢的位置。受试者在干预后进行了一年的随访。环境:康复机构。参与者:患有SCI的成人住院和门诊患者(N = 43)和2至4期压疮(n = 58)。干预措施:每周使用UVC或安慰剂-UVC照射溃疡和伤口周围皮肤3次。终点为伤口闭合或不闭合而出院。主要结果指标:主要结果是相对于基线的每周面积百分比。次要结果是连续几周之间的平均面积变化百分比,表面外观,闭合周数以及干预后对生活质量和伤口状态的影响。结果:除溃疡病持续时间外,所有人口统计学特征的组别相似(P = .02)。总体比较治愈时,各组相似。亚组分析显示,与安慰剂相比,接受UVC治疗的2期臀部溃疡相对于基线的面积百分比在第3、5和7周显着减小。在第1至8周,这些溃疡占26%至76%使用UVC的基线面积与安慰剂的111%至180%(达到显着水平[ASL] ,. 03-.08;效果大小,0.5-0.8)。 2期下肢溃疡相对于基线的面积百分比组相似。在使用UVC的情况下,所有2期溃疡连续几周的组平均面积变化百分比为36.6%,而安慰剂为5.8%(ASL = .09)。对于3至4期溃疡,连续几周之间相对于基线的面积百分比和平均面积百分比变化无组差异。其他所有次要结局的分组相似。结论:UVC对第二阶段的臀部溃疡有益。需要使用更大的样本量,经过仔细考虑的排除标准以及确保所比较组的均一性的策略进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号